🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to demonstrate efficacy of PT003 MDI...
Status
Completed
Location
Pearl Investigative Site
Start Date
2011-06
Trial ID
NCT01349816
The primary objective of this study is to assess the efficacy of Glycopyrro...
Status
Completed
Location
Pearl Investigative Site
Start Date
2012-04
Trial ID
NCT01587079
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of inhaled...
Status
Completed
Location
Woolcock Institute of Medical Research
Start Date
2008-11
Trial ID
NCT00880490
The purpose of this study is to evaluate, after 1 week of dosing, the effic...
Status
Completed
Location
Clinical Research of West Florida, Inc.
Start Date
2010-03
Trial ID
NCT01085045
This is a Phase III randomized, double-blind, parallel group, multi-center,...
Status
Completed
Location
Research Site
Start Date
2016-05-31
Trial ID
NCT02766608
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of inhaled...
Status
Withdrawn
Location
Spartanburg Medical Research
Start Date
2010-07
Trial ID
NCT01043601
Treatments Being Tested
This is a multi-center, randomized, double-blind, parallel group, chronic d...
Status
Completed
Location
Pearl Investigative Site
Start Date
2013-11
Trial ID
NCT01970878
To assess the effect of treatment with Glycopyronnium (GP) MDI administered...
Status
Completed
Location
Research Site
Start Date
2016-12-29
Trial ID
NCT02937584
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of inhaled...
Status
Completed
Location
Pearl Investigative Site
Start Date
2011-05
Trial ID
NCT01349868
This is a Phase III randomized, double-blind, parallel group, multi-center,...
Status
Completed
Location
Research Site
Start Date
2016-04-29
Trial ID
NCT02727660
Treatments Being Tested